BackHappiness Development Group Overview

Happiness Development Group Net Income

Track Happiness Development Group's net income ($2.5B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Net Income

-$85.43M
103.31% YoY

As of Mar 2022

Annual Net Income (TTM)

$2.51B

Trailing 12 months ending Mar 2022

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Happiness Development Group (HAPP) FAQ

Happiness Development Group's net income stands at $2.5B as of March 2022. That is below the Healthcare sector average of $16B. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Happiness Development Group sits lower the Healthcare benchmark ($16B) with a net income of $2.5B. That is roughly 84.8% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

Open the history chart to see whether Happiness Development Group's net income is expanding or contracting. Sustained growth in net income can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Happiness Development Group's net income evolved across reporting periods, while the comparison chart places HAPP next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, net income is commonly used to spot outliers. Happiness Development Group's reading of $2.5B (sector avg $16B) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.